04 December 2018

By Dr Wendy Winnall - PCFA Research Team

Australian study validates a biomarker to predict the success of chemotherapy

Chemotherapy can be a good treatment for metastatic prostate cancer. But it doesn’t work for everyone. Unfortunately it takes months of treatment before the success of chemotherapy can be determined. Researchers are trying to find a good blood test biomarker as an early indicator of chemotherapy success. Major progress in this search has recently been made by Australian researchers.

To read the full article just log into the PCFA Online Community.

If you're not already a member, it is free and easy to join.

Join Online Community Button